• 1
    De CA, Fisher DA, Filiberti R, Blanchi S, Conio M. Barrett's esophagus, esophageal and esophagogastric junction adenocarcinomas: the role of diet. Clin Res Hepatol Gastroenterol 2011; 35: 716.
  • 2
    Kubo A, Block G, Quesenberry CP Jr, Buffler P, Corley DA. Effects of dietary fiber, fats, and meat intakes on the risk of Barrett's esophagus. Nutr Cancer 2009; 61: 60716.
  • 3
    O'Doherty MG, Cantwell MM, Murray LJ, Anderson LA, Abnet CC; FINBAR Study Group. Dietary fat and meat intakes and risk of reflux esophagitis, Barrett's esophagus and esophageal adenocarcinoma. Int J Cancer 2011; 129: 1493502.
  • 4
    Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001; 44: 12946.
  • 5
    Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 2010; 110: 9116.
  • 6
    Cheng C, Tsuneyama K, Kominami R, et al. Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs. Mod Pathol 2005; 18: 138596.
  • 7
    Noguchi T, Sado T, Naruse K, et al. Evidence for activation of Toll-like receptor and receptor for advanced glycation end products in preterm birth. Mediators Inflamm 2010; 2010: 490406.
  • 8
    Prasad A, Bekker P, Tsimikas S. Advanced glycation end products and diabetic cardiovascular disease. Cardiol Rev 2012; 20: 17783.
  • 9
    Takenaka K, Yamagishi S, Matsui T, Nakamura K, Imaizumi T. Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes. Curr Neurovasc Res 2006; 3: 737.
  • 10
    Thornalley PJ. Advanced glycation end products in renal failure. J Ren Nutr 2006; 16: 17884.
  • 11
    Poehlmann A, Kuester D, Malfertheiner P, Guenther T, Roessner A. Inflammation and Barrett's carcinogenesis. Pathol Res Pract 2012; 208: 26980.
  • 12
    Goldberg T, Cai W, Peppa M, et al. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 2004; 104: 128791.
  • 13
    Willett WC. Nutritional Epidemiology. New York: Oxford University Press, 1998.
  • 14
    Friday JE, Bowman SA. MyPyramid Equivalents Database for USDA Survey Food Codes, 1994-2002 Version 1.0. [Online]. Beltsville, MD: USDA, Agricultural Research Service, Beltsville Human Nutrition Research Center, Community Nutrition Research Group, 2006.
  • 15
    Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997; 65: 1220S8S.
  • 16
    WHO. Waist Circumference and Waist–Hip Ratio: Report of a WHO Expert Consultation. Geneva, World Health Organization, 2008.
  • 17
    Jiao L, Kramer JR, Rugge M, et al. Dietary intake of vegetables, folate, and antioxidants and the risk of Barrett's esophagus. Cancer Causes Control 2013; 24: 100514.
  • 18
    Chen KH, Mukaisho K, Sugihara H, Araki Y, Yamamoto G, Hattori T. High animal-fat intake changes the bile-acid composition of bile juice and enhances the development of Barrett's esophagus and esophageal adenocarcinoma in a rat duodenal-contents reflux model. Cancer Sci 2007; 98: 16838.
  • 19
    Clark GW, Smyrk TC, Mirvish SS, et al. Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model. Ann Surg Oncol 1994; 1: 25261.
  • 20
    Koschinsky T, He CJ, Mitsuhashi T, et al. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA 1997; 94: 64749.
  • 21
    Bierhaus A, Humpert PM, Morcos M, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005; 83: 87686.
  • 22
    Farhadi A, Fields J, Banan A, Keshavarzian A. Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett's esophagus, and the latter's progression toward esophageal cancer? Am J Gastroenterol 2002; 97: 226.
    Direct Link:
  • 23
    Taccioli C, Wan SG, Liu CG, et al. Zinc replenishment reverses overexpression of the proinflammatory mediator S100A8 and esophageal preneoplasia in the rat. Gastroenterology 2009; 136: 95366.
  • 24
    Wan SG, Taccioli C, Jiang Y, et al. Zinc deficiency activates S100A8 inflammation in the absence of COX-2 and promotes murine oral-esophageal tumor progression. Int J Cancer 2011; 129: 33145.
  • 25
    Tateno T, Ueno S, Hiwatashi K, et al. Expression of receptor for advanced glycation end products (RAGE) is related to prognosis in patients with esophageal squamous cell carcinoma. Ann Surg Oncol 2009; 16: 4406.